OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
July 02, 2014
As payers refuse to cover new drugs, CMOs take a hit.
June 29, 2014
PharmSource special report shows demand for cytotoxic injectable drugs could tap existing CMO capacity.
June 02, 2014
With budgets growing, clients see CMOs' costs as less crucial.
Paul Nelles of Vetter Development Service discusses prefilled syringes.
May 30, 2014
DCAT's Sharp Sourcing 2014 educational program offers pharmaceutical and biopharmaceutical companies a forum to gain best practice insights in sourcing and procurement.
May 02, 2014
Industry experts discuss how extractables and leachables studies are designed using a risk-based approach.
Data integrity in the analytical laboratory is an area of increasing focus for regulators such as FDA.
The CMO industry's value proposition is limiting its market penetration.
Biopharma companies should not overlook India's growing market.
April 02, 2014
The international pharmaceutical industry is changing its approach to R&D and is increasingly relying on outsourcing for drug discovery.